1/2024
vol. 16
Editorial
Letter from the Editor-in-Chief
Data publikacji online: 2024/03/29
Article file
1. Morales MG, Martinez-Regueira F, Rodriguez-Spiteri N et al. Minimally invasive tumor bed implant (MITBI) and peri-operative high-dose-rate brachytherapy (PHDRBT) for accelerated minimal breast irradiation (AMBI) or anticipated boost (A-PHDRBT-boost) in breast-conserving surgery for ductal carcinoma in situ. J Contemp Brachytherapy 2020; 12: 521-532.
2.
Vavassori A, Riva G, Cavallo I et al. High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study. J Contemp Brachytherapy 2020; 12: 207-215.
3.
Major T, Fröhlich G, Mészáros N et al. Does inverse planning improve plan quality in interstitial high-dose-rate breast brachytherapy? J Contemp Brachytherapy 2020; 12: 166-174.
4.
Cozzi S, Jamal D, Slocker A et al. Second breast-conserving therapy with interstitial brachytherapy (APBI) as a salvage treatment in ipsilateral breast tumor recurrence: a retrospective study of 40 patients. J Contemp Brachytherapy 2019; 11: 101-107.
5.
Cozzi S, Laplana M, Najjari D et al. Advantages of intraoperative implant for interstitial brachytherapy for accelerated partial breast irradiation either frail patients with early-stage disease or in locally recurrent breast cancer. J Contemp Brachytherapy 2018; 10: 97-104.
6.
Chatterjee A, Grover S, Gurram L et al. Patterns of cervical cancer brachytherapy in India: results of an online survey supported by the Indian Brachytherapy Society. J Contemp Brachytherapy 2019; 11: 527-533.
7.
Mahantshetty U, Gudi S, Singh R et al. Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy. J Contemp Brachytherapy 2019; 11: 293-306.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
